| 1 |
Liu W, Guo NY, Wang JQ, et al. Osteoarthritis: Mechanisms and Therapeutic Advances [J]. Med Comm, (2020), 2025, 6(8): e70290.
|
| 2 |
Hu Y, Chen X, Wang S, Jing Y, Su J. Subchondral bone microenvironment in osteoarthritis and pain [J]. Bone Res, 2021, 9(1): 20.
|
| 3 |
Tang S, Zhang C, Oo WM, et al. Osteoarthritis [J]. Nat Rev Dis Primers, 2025, 11(1): 10.
|
| 4 |
Coryell PR, Diekman BO, Loeser RF. Mechanisms and therapeutic implications of cellular senescence in osteoarthritis [J]. Nat Rev Rheumatol, 2021, 17(1): 47-57.
|
| 5 |
Loeser RF, Collins JA, Diekman BO. Ageing and the pathogenesis of osteoarthritis [J]. Nat Rev Rheumatol, 2016, 12(7): 412-420.
|
| 6 |
Yao Q, Wu X, Tao C, et al. Osteoarthritis: pathogenic signaling pathways and therapeutic targets [J]. Signal Transduct Target Ther, 2023, 8(1): 56.
|
| 7 |
Yamaura K, Nelson AL, Nishimura H, et al. Therapeutic potential of senolytic agent quercetin in osteoarthritis: A systematic review and meta-analysis of preclinical studies [J]. Ageing Res Rev, 2023, 90: 101989.
|
| 8 |
Ruan H, Zhu T, Wang T, et al. Quercetin Modulates Ferroptosis via the SIRT1/Nrf-2/HO-1 Pathway and Attenuates Cartilage Destruction in an Osteoarthritis Rat Model [J]. Int J Mol Sci, 2024, 25(13): 7461.
|
| 9 |
Yao H, Xu J, Wang J, et al. Combination of magnesium ions and vitamin C alleviates synovitis and osteophyte formation in osteoarthritis of mice [J]. Bioact Mater, 2020, 6(5): 1341-1352.
|
| 10 |
Huang YF, Wang G, Ding L, et al. Lactate-upregulated NADPH-dependent NOX4 expression via HCAR1/PI3K pathway contributes to ROS-induced osteoarthritis chondrocyte damage [J]. Redox Biol, 2023, 67: 102867.
|
| 11 |
Gan X, Li J, Li S, et al. Integrating superlubricative nanomaterials with precision drug delivery for advanced osteoarthritis therapy [J]. Mater Today Bio, 2025, 35: 102359.
|
| 12 |
Murakami A, Ashida H, Terao J. Multitargeted cancer prevention by quercetin [J]. Cancer Lett, 2008, 269(2): 315-325.
|
| 13 |
Qiu L, Luo Y, Chen X. Quercetin attenuates mitochondrial dysfunction and biogenesis via upregulated AMPK/SIRT1 signaling pathway in OA rats [J]. Biomed Pharmacother, 2018, 103: 1585-1591.
|
| 14 |
Han Z, Gao X, Wang Y, et al. Ultrasmall iron-quercetin metal natural product nanocomplex with antioxidant and macrophage regulation in rheumatoid arthritis [J]. Acta Pharm Sin B, 2023, 13(4): 1726-1739.
|
| 15 |
Court AC, Vega-Letter AM, Parra-Crisóstomo E, et al. Mitochondrial transfer balances cell redox, energy and metabolic homeostasis in the osteoarthritic chondrocyte preserving cartilage integrity [J]. Theranostics, 2024, 14(17): 6471-6486.
|
| 16 |
Deng Z, Long D, Li C, et al. IRF1-mediated upregulation of PARP12 promotes cartilage degradation by inhibiting PINK1/Parkin dependent mitophagy through ISG15 attenuating ubiquitylation and SUMOylation of MFN1/2 [J]. Bone Res, 2024, 12(1): 63.
|
| 17 |
Yuan YS, Li HY, Lu H, et al. Reprogramming mitochondrial metabolism to enhance macrophages polarization by ROS-responsive nanoparticles for osteoarthritis [J]. Biomaterials, 2025, 322: 123395.
|
| 18 |
Xian B, Yan J, De C, et al. An Inducible Nitric Oxide Synthase Dimerization Inhibitor Prevents the Progression of Osteoarthritis [J]. Front Pharmacol, 2022, 13: 861183.
|
| 19 |
Shao Z, Wang B, Shi Y, et al. Senolytic agent Quercetin ameliorates intervertebral disc degeneration via the Nrf2/NF-κB axis [J]. Osteoarthritis Cartilage, 2021, 29(3): 413-422.
|
| 20 |
Jiang C, He X, Lou A, et al. Trigonelline Shields Chondrocytes from Oxidative Damage in Osteoarthritis through Activation of the Keap1/Nrf2/ARE Signaling Pathway [J]. Appl Biochem Biotechnol, 2025, 197(7): 4586-4601.
|
| 21 |
Sun K, Jing X, Guo J, Yao X, Guo F. Mitophagy in degenerative joint diseases [J]. Autophagy, 2021, 17(9): 2082-2092.
|
| 22 |
Riegger J, Schoppa A, Ruths L, et al. Oxidative stress as a key modulator of cell fate decision in osteoarthritis and osteoporosis: a narrative review [J]. Cell Mol Biol Lett, 2023, 28(1): 76.
|
| 23 |
Liu S, Cheng S, Chen B, et al. Microvesicles-hydrogel breaks the cycle of cellular senescence by improving mitochondrial function to treat osteoarthritis [J]. J Nanobiotechnology, 2023, 21(1): 429.
|
| 24 |
Xian H, Watari K, Sanchez-Lopez E, et al. Oxidized DNA fragments exit mitochondria via mPTP- and VDAC-dependent channels to activate NLRP3 inflammasome and interferon signaling [J]. Immunity, 2022, 55(8): 1370-1385.
|
| 25 |
Mendoza A, Patel P, Robichaux D, et al. Inhibition of the mPTP and Lipid Peroxidation Is Additively Protective Against I/R Injury [J]. Circ Res, 2024, 134(10): 1292-1305.
|
| 26 |
Zhang H, Tsui CK, Garcia G, et al. The extracellular matrix integrates mitochondrial homeostasis [J]. Cell, 2024, 187(16): 4289-4304.
|
| 27 |
Zhou F, Mei J, Han X, et al. Kinsenoside attenuates osteoarthritis by repolarizing macrophages through inactivating NF-κB/MAPK signaling and protecting chondrocytes [J]. Acta Pharm Sin B, 2019, 9(5): 973-985.
|
| 28 |
Jin Y, Zhang Q, Qin X, et al. Carbon dots derived from folic acid attenuates osteoarthritis by protecting chondrocytes through NF-κB/MAPK pathway and reprogramming macrophages [J]. J Nanobiotechnology, 2022, 20(1): 469.
|
| 29 |
Zhao X, Lin J, Liu F, et al. Targeting p21-Positive Senescent Chondrocytes via IL-6R/JAK2 Inhibition to Alleviate Osteoarthritis [J]. Adv Sci (Weinh), 2025, 12(11): e2410795.
|